Category Archive: HBOT

HBOT in DFU Treatment: Pressure still on to find compelling evidence for widespread use

October 20, 2017

Anna Kitabjian, RN, MSN October 16, 2017   Efficacy of Hyperbaric Oxygen Therapy in Diabetic Foot Ulcers Share this content: facebook twitter linkedin google Email Print Researchers evaluated the efficacy and safety profile of using hyperbaric oxygen therapy for the treatment of diabetic foot ulcers. The use of hyperbaric oxygen therapy (HBOT) in the treatment of diabetic foot ulcers may not result in a difference in outcomes when compared with standard therapy (ST), according to a study published by Clinical Therapeutics….

Read More →

HBOT Takes a Dive: Healing rates for HBO treated DFU’s the same as sham.

January 13, 2016

Source: Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial

Read More →

Hyperbaric Oxygen Therapy in Wound Care: A Service Under True Pressure | Todays Wound Clinic

October 19, 2014

Hyperbaric Oxygen Therapy in Wound Care: A Service Under True Pressure | Todays Wound Clinic.

Read More →

Effectiveness of HBOT: The muddied waters clearing.

May 9, 2013

Foot ulcer experts weigh use of hyperbaric oxygen EMAIL SUBSCRIPTION 9   Photo courtesy of MedStar Georgetown University Hospital. Two February publications sum up the polarizing nature of hyperbaric oxygen therapy (HBOT) for treating recalcitrant diabetic foot ulcers. A meta-analysis supported use of HBOT, while a large cohort study found a lack of effectiveness in community-care settings. By Larry Hand Just as boxers have to show their mettle every time they get into the ring, advocates of hyperbaric oxygen therapy…

Read More →

Deflating Results for HBOT: Is this the last breath for oxygen therapy?

February 25, 2013

Oxygen treatment may not help foot ulcers inShare1 Share this Email Print   Related News Just say don't: Doctors question routine tests and treatments Thu, Feb 21 2013 Repros jumps on FDA go-ahead for testosterone drug study Thu, Feb 21 2013 Gilead hepatitis C drug meets goal of fourth late-stage study Tue, Feb 19 2013 Menus labels may sway those who need them most Fri, Feb 15 2013 More thorough dialysis may reduce deaths Thu, Feb 14 2013   Related…

Read More →